Patient-safety area | Reference meta-analysis | Intervention | Patient outcome | Effect size (95% CI) significant effect sizes are bold | p Value | Studies in meta-analysis (n) (eligible studies* (n)) |
---|---|---|---|---|---|---|
Adverse drug event Medication review | Holland et al24 | Pharmacist-led medication review | Mortality | RR 0.96 (0.82 to 1.13) | 0.62 | 22 |
Christensen and Lundh26 | Medication review | Mortality | RR 0.98 (0.78 to 1.23) | 0.86 | 4 | |
Hohl et al27 | Medication review | Mortality | OR 1.09 (0.69 to 1.72) | 0.71 | 3 | |
Adverse drug event Computerised advice on drug dosage | Durieux et al28 | Computerised advice on drug dosage | Mortality | RR 0.81 (0.37 to 1.81) | 0.61 | 6 |
Gillaizeau et al29 | Computerised advice on drug dosage | Mortality | RR 1.08 (0.80 to 1.45) | 0.61 | 10 | |
Bayoumi et al30 | Computerised drug-laboratory alerts | Adverse events (bleeding and thrombosis) | OR 0.88 (0.78 to 1.00) | 0.05 | 4 | |
Adverse drug event Multicomponent interventions | Davey et al33 | Intervention for antimicrobial therapy | Mortality | RR 0.92 (0.69 to 1.22) | 0.56 | 3 |
Antibiotic guideline for pneumonia | Mortality | RR 0.89 (0.82 to 0.97) | 0.01 | 4 | ||
Decrease excessive prescribing | Mortality | RR 0.92 (0.81 to 1.06) | 0.25 | 11 | ||
Wang et al36 | Pharmacist interventions | Preventable adverse drug events | OR 0.23 (0.11 to 0.48) | <0.01 | 3 (2) | |
Infections | Blot et al39 | Care bundle/checklist interventions | CLABSI | OR 0.39 (0.33 to 0.46) | <0.01 | 41 (5) |
CLABSI rate at 3 months | OR 0.30 (0.10 to 0.88) | 0.03 | 6 (4) | |||
Meddings et al40 | Catheter reminder and stop order | CAUTI episodes per 1000 catheter days | RR 0.47 (0.30 to 0.64) | <0.01 | 11 (1) | |
CAUTI | RR 0.72 (0.52 to 0.99) | 0.05 | 8 (2) | |||
Damiani et al41 | Sepsis bundle | Mortality | OR 0.66 (0.61 to 0.72) | <0.01 | 48 (3) | |
Delirium | Hempenius et al47 | Multicomponent interventions, including cognitive screening, proactive geriatric consultation and psychotherapy | Incidence of delirium | OR 0.58 (0.38 to 0.92) | NR | 5 |
One-component interventions | Incidence of delirium | OR 1.05 (0.09 to 11.57) | NR | 2 | ||
Hshieh et al50 | Multicomponent intervention, including early mobility, cognition and orientation | Incidence of delirium | OR 0.47 (0.38 to 0.58) | <0.01 | 11 (7) | |
Martinez et al51 | Multicomponent intervention, including physiotherapy, daily reorientation, family involvement and staff/family-member education | Incidence of delirium | RR 0.73 (0.63 to 0.85) | <0.01 | 7 | |
Adverse event after hospital discharge or clinical handover | Griffiths et al52 | Nursing-led inpatients units | Mortality | OR 1.10 (0.56 to 2.16) | 0.64 | 7 |
Mortality 3 or 6 months post admission | OR 0.96 (0.63 to 1.47) | 0.62 | 6 | |||
Conroy et al53 | Comprehensive geriatric assessment | Mortality | RR 0.92 (0.55 to 1.52) | 0.77 | 5 | |
Niven et al54 | Critical-care transition programmes | Mortality | RR 0.84 (0.66 to 1.05) | 0.1 | 3 (2) | |
Shepperd et al56 | Discharge planning from hospital to home | Mortality at 6–9 months | RR 1.00 (0.79 to 1.26) | 0.69 | 6 | |
Falls | RR 0.87 (0.50 to 1.49) | 0.61 | 1 | |||
Lowthian et al57 | Optimised ED discharge | Mortality up to 18 months postdischarge | OR 1.01 (0.70 to 1.47) | 0.94 | 2 | |
Zhu et al58 | Nurse-led early-discharge planning | Mortality | RR 0.70 (0.52 to 0.95) | 0.02 | 5 | |
Fall | Oliver et al59 | Multicomponent intervention | Falls | RaR 0.82 (0.68 to 1.00) | NR | 12 |
Fallers | RR 0.95 (0.71 to 1.27) | NR | 12 | |||
Fractures | RaR 0.59 (0.22 to 1.58) | NR | 12 | |||
Coussement et al60 | Multicomponent intervention | Falls | RR 0.82 (0.65 to 1.03) | NR | 4 | |
Number of fallers | RR 0.87 (0.70 to 1.08) | NR | 4 | |||
Cameron et al61 | Multicomponent interventions | Rate of falls | RaR 0.69 (0.49 to 0.96) | 0.03 | 4 | |
Risk of falling | RR 0.71 (0.46 to 1.09) | 0.12 | 3 | |||
Exercises | Risk of falling | RR 0.36 (0.14 to 0.93) | 0.04 | 2 | ||
Adverse event in surgery | Bergs et al66 | WHO surgical safety checklist | Any complication | RR 0.59 (0.47 to 0.74) | <0.01 | 5 |
Mortality | RR 0.77 (0.60 to 0.98) | 0.04 | 4 (3) | |||
Surgical-site infections | RR 0.57 (0.41 to 0.79) | <0.01 | 5 | |||
Cardiopulmonary arrest | Chan et al69 | Rapid response team | Mortality | RR 0.92 (0.82 to 1.04) | NR | 16 |
Cardiopulmonary arrest | RR 0.65 (0.55 to 0.77) | NR | 16 | |||
Maharaj et al71 | Rapid response team | Mortality | RR 0.91 (0.85 to 0.97) | <0.01 | 4 | |
Cardiopulmonary arrest | RR 0.74 (0.56 to 0.98) | 0.04 | 2 | |||
Venous thromboembolism | Kahn et al72 | Alerts | All venous thromboembolism | RR 0.85 (0.49 to 1.46) | NR | 3 |
Multicomponent interventions | All venous thromboembolism | RR 1.01 (0.51 to 1.98) | NR | 5 | ||
Symptomatic deep vein thromboembolism | RR 0.59 (0.18 to 1.98) | NR | 3 | |||
Staffing | Butler et al75 | Addition of specialist nursing post to staffing | In-hospital mortality | RR 0.96 (0.59 to 1.56) | 0.86 | 1 |
Postdischarge adverse events | RR 1.03 (0.70 to 1.53) | 0.87 | 1 | |||
Increasing the proportion of support staff | Mortality in trauma unit | RR 0.41 (0.16 to 1.01)) | 0.05 | 1 | ||
Mortality in hospital | RR 0.56 (0.29 to 1.09) | 0.09 | 1 | |||
Mortality at 4 months | RR 0.57 (0.34 to 0.95) | 0.03 | 1 | |||
Pannick et al76 | Interdisciplinary teams | Mortality | wRR 0.92 (0.82 to 1.05) | NR | 7 | |
Team practice interventions | Mortality | wRR 0.67 (0.45 to 0.99) | NR | 2 | ||
Clinical pathway | Rotter et al79 | Clinical pathway | Mortality | OR 0.84 (0.64 to 1.11) | 0.23 | 3 |
Complications up to 3 months | OR 0.31 (0.13 to 0.72) | 0.07 | 1 | |||
In-hospital complications | OR 0.58 (0.36 to 0.94) | 0.03 | 5 |
*Study design in accordance with methodological criteria of the Cochrane EPOC review group and quantitative data on adverse event rates were reported.
CAUTI, catheter-associated urinary tract infection; CLABSI, central-line-associated bloodstream infection; EPOC, Effective Practice and Organisation of Care; NR, not reported; RaR, rate ratio; RR, risk/relative ratio; wRR, weighted risk ratio.